Millennium Management LLC Grows Stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Millennium Management LLC grew its stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 96.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 711,691 shares of the company's stock after buying an additional 350,213 shares during the period. Millennium Management LLC owned approximately 2.54% of Establishment Labs worth $32,788,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Quarry LP bought a new stake in shares of Establishment Labs during the 4th quarter worth $27,000. R Squared Ltd purchased a new position in shares of Establishment Labs in the 4th quarter worth about $36,000. KLP Kapitalforvaltning AS bought a new position in shares of Establishment Labs during the 4th quarter valued at about $161,000. Hood River Capital Management LLC raised its holdings in shares of Establishment Labs by 236.4% during the 4th quarter. Hood River Capital Management LLC now owns 5,920 shares of the company's stock valued at $273,000 after buying an additional 4,160 shares in the last quarter. Finally, Handelsbanken Fonder AB lifted its position in Establishment Labs by 32.3% in the 4th quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company's stock worth $378,000 after buying an additional 2,000 shares during the last quarter. Institutional investors own 72.91% of the company's stock.

Establishment Labs Trading Up 2.7%

Shares of NASDAQ:ESTA traded up $0.97 during trading on Thursday, reaching $36.85. 247,089 shares of the company traded hands, compared to its average volume of 470,242. The company has a current ratio of 3.62, a quick ratio of 2.29 and a debt-to-equity ratio of 5.94. Establishment Labs Holdings Inc. has a 52-week low of $26.56 and a 52-week high of $58.00. The firm has a market capitalization of $1.07 billion, a price-to-earnings ratio of -14.28 and a beta of 0.73. The business's fifty day moving average is $34.42 and its 200-day moving average is $38.10.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported ($0.70) EPS for the quarter, beating analysts' consensus estimates of ($0.83) by $0.13. The company had revenue of $41.38 million during the quarter, compared to analyst estimates of $41.15 million. Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. The firm's revenue was up 11.3% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.58) EPS. As a group, analysts forecast that Establishment Labs Holdings Inc. will post -2.41 EPS for the current year.

Wall Street Analyst Weigh In

ESTA has been the topic of a number of recent research reports. Wall Street Zen cut shares of Establishment Labs from a "hold" rating to a "sell" rating in a research report on Thursday. Needham & Company LLC raised shares of Establishment Labs from a "hold" rating to a "buy" rating and set a $48.00 price objective for the company in a research note on Wednesday, May 14th. BTIG Research assumed coverage on shares of Establishment Labs in a research report on Friday, May 16th. They issued a "buy" rating and a $62.00 target price on the stock. Finally, Stephens reissued an "overweight" rating and issued a $52.00 price target on shares of Establishment Labs in a research note on Thursday, March 6th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $55.33.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.